SRPT vs VABK · rev $1.13B vs P/E 11, rev $38.4M
Sarepta Therapeutics Inc (SRPT) versus Virginia National Bankshares Corp (VABK) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Virginia National Bankshares Corp (VABK) is a banks - regional company listed on US.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported VABK revenue for 2026-06-30 was $38.4M. Net income was $14.3M. VABK currently screens at market cap $203.0M and trailing P/E 11.4.
SRPT currently screens at market cap $2.34B. VABK currently screens at market cap $203.0M and trailing P/E 11.4.
Not investment advice. Open the SRPT and VABK stock pages for the full models.
Not investment advice.